Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings

• প্রধান লেখক: Irsan Hasan (লেখক), Ignatia Sinta Murti (লেখক), Putut Bayupurnama (লেখক), Kemal Fariz Kalista (লেখক), Christina Hill-Zabala (লেখক), Dennis Kananda (লেখক), Elisabet Viayna (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BioExcel Publishing Ltd, 2024-04-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background: Human albumin (HA) is an effective adjuvant treatment for patients with cirrhosis developing spontaneous bacterial peritonitis (SBP), hepatorenal syndrome (HRS) and ascites requiring large-volume paracentesis (LVP). However, cost remains a barrier to use, particularly in resource-limited...